Problem statement: Answer the MCQ question.
Query: Which compound exhibits a 14.123\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. COC(=O)c1ccc(/C=N/NC(=S)NCCN2CCOCC2)cc1
b. O=C(O)CCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)[C@@H]2C1=O
c. COc1ccc(CCNC(=O)c2cc(-c3cc(C)c(C)cc3O)n[nH]2)cc1OC
Answer: b. O=C(O)CCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)[C@@H]2C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(O)CCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)[C@@H]2C1=O
O=C(O)CCCN1C(=O)C2C3c4ccccc4C(c4ccccc43)[C@@H]2C1=O
4-[(19S)-16,18-dioxo-17-azapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaen-17-yl]butanoic acid